- Home
- RDWR vs RLAY Comparison
RDWR vs RLAY Comparison
Compare RDWR & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDWR
- RLAY
- Stock Information
- Founded
- RDWR 1996
- RLAY 2015
- Country
- RDWR Israel
- RLAY United States
- Employees
- RDWR N/A
- RLAY N/A
- Industry
- RDWR EDP Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDWR Technology
- RLAY Health Care
- Exchange
- RDWR Nasdaq
- RLAY Nasdaq
- Market Cap
- RDWR 849.8M
- RLAY 893.0M
- IPO Year
- RDWR 1999
- RLAY 2020
- Fundamental
- Price
- RDWR $21.04
- RLAY $8.21
- Analyst Decision
- RDWR Buy
- RLAY Strong Buy
- Analyst Count
- RDWR 2
- RLAY 9
- Target Price
- RDWR $23.00
- RLAY $20.88
- AVG Volume (30 Days)
- RDWR 128.3K
- RLAY 3.0M
- Earning Date
- RDWR 10-30-2024
- RLAY 10-31-2024
- Dividend Yield
- RDWR N/A
- RLAY N/A
- EPS Growth
- RDWR N/A
- RLAY N/A
- EPS
- RDWR N/A
- RLAY N/A
- Revenue
- RDWR $259,005,000.00
- RLAY $35,208,000.00
- Revenue This Year
- RDWR $5.93
- RLAY N/A
- Revenue Next Year
- RDWR $6.81
- RLAY N/A
- P/E Ratio
- RDWR N/A
- RLAY N/A
- Revenue Growth
- RDWR N/A
- RLAY 3637.58
- 52 Week Low
- RDWR $13.53
- RLAY $5.70
- 52 Week High
- RDWR $23.05
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- RDWR 49.11
- RLAY 55.57
- Support Level
- RDWR $19.72
- RLAY $6.70
- Resistance Level
- RDWR $22.87
- RLAY $10.72
- Average True Range (ATR)
- RDWR 0.52
- RLAY 0.77
- MACD
- RDWR -0.16
- RLAY 0.13
- Stochastic Oscillator
- RDWR 48.37
- RLAY 41.99
About RDWR Radware Ltd.
Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. The company generates maximum revenue from the United States.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).